Peer Support Program to Improve Self-Care in Older Adults with Type 2 Diabetes in Rural Appalachia
Led by The University of Texas Medical Branch, Galveston · Updated on 2026-06-17
25
Participants Needed
2
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating peer coaching models to support self-care in older adults with unmanaged Type 2 Diabetes Mellitus T2DM living in rural Appalachian Kentucky. This study aims to understand how effective peer coaching is in promoting diabetes self-management and which aspects of the peer support are most helpful. The intervention builds on the unique social connections within the community and is designed to improve self-care behaviors in this population.
The study involves peer coaches who have well-managed T2DM and peer participants with unmanaged T2DM. Peer coaches receive training to develop coaching skills before the intervention begins. Peer participants are assigned to one of four groups based on whether they select or are matched with a peer coach, and the frequency of contact is either weekly or every two weeks. Peer coaches maintain records of interactions, and researchers will compare different coaching approaches and contact frequencies to assess their impact.
Participants engage in the intervention over six months, with assessments at baseline, the end of intervention 6 months, and follow-ups at 3 and 6 months post-intervention. Researchers collect various measures including changes in blood sugar control HbA1c, diabetes empowerment, quality of life, social support, depression, diabetes-related problems, self-management behaviors, daily living activities, social networks, diabetes knowledge, problem-solving skills, medication adherence, and frailty. Stakeholders are involved at key points to provide feedback, and selected participants contribute to interviews after the study concludes.
CONDITIONS
Brief Title
OASIS: Peer Support for T2DM in Appalachia (Peer Coaches)
Research Team
B
Brittany L. Smalls, PhD
K
Kindness C. Akwari, MS
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborating Sponsor
How This Trial Compares With Other Options
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
Peer coaching weekly (Group A)
Peer coaching bi‑weekly (Group B)
Peer coaching weekly (Group C)
Peer coaching bi‑weekly (Group D)
Typical diabetes self‑management support
What the approach is
Peer coaching delivered weekly under condition A
Peer coaching delivered every two weeks under condition B
Peer coaching delivered weekly under condition C
Peer coaching delivered every two weeks under condition D
Patients typically receive standard diabetes self‑management support without structured peer coaching
Primary purpose
Evaluate peer coaching frequency effect on glycemic control and psychosocial outcomes
Evaluate peer coaching frequency effect on glycemic control and psychosocial outcomes
Evaluate peer coaching frequency effect on glycemic control and psychosocial outcomes
Evaluate peer coaching frequency effect on glycemic control and psychosocial outcomes
Represents typical self‑management support offered outside peer‑coaching programs
Evidence status
Evidence pending trial results
Evidence pending trial results
Evidence pending trial results
Evidence pending trial results
Peer support interventions generally improve glycemic control and self‑management when added to usual care
Important limitations
No results yet available; small sample size (about 25 participants total)
No results yet available; small sample size
No results yet available; small sample size
No results yet available; small sample size
Effectiveness of peer support varies across designs; comparisons across heterogeneous studies may not apply directly to this trial’s population or design
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 55Years +
All Genders
Eligibility Criteria
You may qualify if you...
Age greater than or equal to 55 years
Resident in Rural Kentucky
Positive diagnosis of Type 2 Diabetes Mellitus
HbA1c less than 7.5 for peer coaches
Passing score on cognitive assessment administered by study personnel
English Speaking
You will not qualify if you...
Age less than 55 years
Not a resident of a Rural Kentucky County
No Type 2 Diabetes Mellitus Diagnosis
Cognitive Impairment
Non-English Speaking
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Intervention
Duration - 6 months
Participants interact with peer coaches through weekly or biweekly contacts to support diabetes self-management. Peer coaches have been trained and record details of their interactions.
Weekly or biweekly contacts depending on group assignment
Follow-up
Duration - 6 months
Participants complete assessments at 3 and 6 months after the intervention to evaluate ongoing diabetes management and quality of life.
2 follow-up visits
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
HEALTH_SERVICES_RESEARCH
Number of Arms
4
Similar Trials
Study of Daily Movement and Lifestyle Patterns in Adults with Type 2 Diabetes Compared to Healthy Adults
Phase 12a Study Evaluating Safety and Effects of ARO-ALK7 in Adults With Obesity, With or Without Type 2 Diabetes
Comparing Empagliflozin and Dapagliflozin for Treatment of Type 2 Diabetes, Chronic Kidney Disease, and Heart Failure Using Cluster Randomization in Electronic Health Records
Comparing Enavogliflozin With Other SGLT2 Inhibitors for Heart and Kidney Health in Adults With Type 2 Diabetes
Comparing Cleerly Coronary Artery Disease Stage-Based Care With Risk Factor-Based Care to Prevent Cardiovascular Events
Heart Disease Risk Study in Adults Aged 40 to 69 Newly Diagnosed with Type 2 Diabetes in Southeast Asia
Evaluating Once-Weekly Subcutaneous NNC0662-0419 Compared to Semaglutide and Placebo for Adults with Type 2 Diabetes
Evaluating the Safety and Effectiveness of Weekly UBT251 Injections Compared to Semaglutide in Adults with Type 2 Diabetes
Phase 1 Study to Test Safety and Tolerability of NNC1679-0001 in Healthy Adults and Adults With Type 2 Diabetes
Study of Weekly CagriSema Injections Compared to Placebo for Blood Sugar and Weight Control in Children and Adolescents with Type 2 Diabetes
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Older adults using social support to improve self-care (OASIS): Adaptation, implementation and feasibility of peer support for older adults with T2D in appalachia: A feasibility study protocol.
Brittany L Smalls, Aaron Kruse-Diehr, Courtney L Ortz...